GLP-1 Agonism Stimulates Brown Adipose Tissue Thermogenesis and Browning Through Hypothalamic AMPK
The DOI matches its Crossref record; 50 of the 52 references it cites were found in a registry or an index.
Abstract
GLP-1 receptor (GLP-1R) is widely located throughout the brain, but the precise molecular mechanisms mediating the actions of GLP-1 and its long-acting analogs on adipose tissue as well as the brain areas responsible for these interactions remain largely unknown. We found that central injection of a clinically used GLP-1R agonist, liraglutide, in mice stimulates brown adipose tissue (BAT) thermogenesis and adipocyte browning independent of nutrient intake. The mechanism controlling these actions is located in the hypothalamic ventromedial nucleus (VMH), and the activation of AMPK in this area is sufficient to blunt both central liraglutide-induced thermogenesis and adipocyte browning. The decreased body weight caused by the central injection of liraglutide in other hypothalamic sites was sufficiently explained by the suppression of food intake. In a longitudinal study involving obese type 2 diabetic patients treated for 1 year with GLP-1R agonists, both exenatide and liraglutide increased energy expenditure. Although the results do not exclude the possibility that extrahypothalamic areas are also modulating the effects of GLP-1R agonists, the data indicate that long-acting GLP-1R agonists influence body weight by regulating either food intake or energy expenditure through various hypothalamic sites and that these mechanisms might be clinically relevant.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Beiroa (36) et al. injected GLP-1 analog, liraglutide (LIR), into mice. LIR was found to stimulate the thermogenesis of brown adipose tissue and the browning of adipose cells, independent of the intake of nutrients. It can increase the thermogenesis and utilization of triacylglycerol-derived fatty acids and glucose in brown adipocytes and reduce the lipid content through the central GLP-1R agonist”
From GLP−1 receptor agonists for the treatment of obesity: Role as a promising approach (2023) · cites this paper as [36]
In the citing paper
“Nevertheless, the results showed reduced or unaltered REE in both studies after treatment with GLP-1 Ras, as opposed to the first studies, where GLP-1 RAs led to a raised REE, mainly when adjusted for fat-free mass [101].”
From Adipose Tissue: A Novel Target of the Incretin Axis? A Paradigm Shift in Obesity-Linked Insulin Resistance (2024) · cites this paper as [101]
In the citing paper
“Furthermore, a central injection of liraglutide in mice stimulated thermogenesis of BAT and browning of white adipocytes independently of nutrient intake [176].”
From Dysregulated epicardial adipose tissue as a risk factor and potential therapeutic target of heart failure with preserved ejection fraction in diabetes (2022) · cites this paper as [176]
In the citing paper
“In particular, feeding activates the secretion of periprandial gut hormones, such as CCK, GLP‐1, or secretin 105, 106, 107.”
From Inter‐organ communication: a gatekeeper for metabolic health (2019) · cites this paper as [105]
Citations
Cites
Identification and Importance of Brown Adipose Tissue in Adult Humans
Cypess, A. M., Lehman, S., Williams, G., Tal, I., Rodman, D., Goldfine, A. B., Kuo, F. C., Palmer, E. L., Tseng, Y.-H., Doria, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810780 · Cited by 4,399
Cold-Activated Brown Adipose Tissue in Healthy Men
van Marken Lichtenbelt, W. D., Vanhommerig, J. W., Smulders, N. M., Drossaerts, J. M. A. F. L., Kemerink, G. J., Bouvy, N. D., Schrauwen, P., & Teule, G. J. J. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808718 · Cited by 3,452
Beige Adipocytes Are a Distinct Type of Thermogenic Fat Cell in Mouse and Human
Wu, J., Boström, P., Sparks, L. M., Ye, L., Choi, J. H., Giang, A.-H., Khandekar, M., Virtanen, K. A., Nuutila, P., Schaart, G., et al. (2012) · Cell · doi:10.1016/j.cell.2012.05.016 · Cited by 3,319
Functional Brown Adipose Tissue in Healthy Adults
Virtanen, K. A., Lidell, M. E., Orava, J., Heglind, M., Westergren, R., Niemi, T., Taittonen, M., Laine, J., Savisto, N.-J., Enerbäck, S., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808949 · Cited by 3,058
A role for glucagon-like peptide-1 in the central regulation of feeding
Turton, M. D., O'Shea, D., Gunn, I., Beak, S. A., Edwards, C. M. B., Meeran, K., Choi, S. J., Taylor, G. M., Heath, M. M., Lambert, P. D., et al. (1996) · Nature · doi:10.1038/379069a0 · Cited by 1,950 · cited 4×
“In agreement with previous findings (7,17,18), we found that the central stimulation of GLP-1R reduces food intake and body weight.”
BackgroundResultInfluentialGlucagon-like peptide-1 7–36: a physiological incretin in man
Kreymann, B., Ghatei, M. A., Williams, G., & Bloom, S. R. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91194-9 · Cited by 1,928 · cited 1×
“Among its numerous physiological effects (3), GLP-1 increases insulin and decreases glucagon secretion in a glucose-dependent manner (4,5), slows gastric emptying (6), increases glucose disposal, and decreases appetite (7).”
BackgroundBuse, J. B., Rosenstock, J., Sesti, G., Schmidt, W. E., Montanya, E., Brett, J. H., Zychma, M., & Blonde, L. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60659-0 · Cited by 1,503 · cited 9×
“In addition to the functional data on liraglutide from the mouse study, we analyzed data from a cohort of obese patients with T2D who had been treated for 1 year with the antidiabetic drugs metformin and metformin in combination with the GLP-1R agonists exenatide and liraglutide (Table 1).”
BackgroundInfluentialPharmacology, physiology, and mechanisms of incretin hormone action.
Campbell, J. E., & Drucker, D. J. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.04.008 · Cited by 1,500 · cited 1×
“Among its numerous physiological effects (3), GLP-1 increases insulin and decreases glucagon secretion in a glucose-dependent manner (4,5), slows gastric emptying (6), increases glucose disposal, and decreases appetite (7).”
BackgroundAstrup, A., Rössner, S., Van Gaal, L., Rissanen, A., Niskanen, L., Al Hakim, M., Madsen, J., Rasmussen, M. F., & Lean, M. E. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61375-1 · Cited by 1,163
Garber, A., Henry, R., Ratner, R., Garcia-Hernandez, P. A., Rodriguez-Pattzi, H., Olvera-Alvarez, I., Hale, P. M., Zdravkovic, M., & Bode, B. (2009) · The Lancet · doi:10.1016/s0140-6736(08)61246-5 · Cited by 1,057
Mojsov, S., Weir, G. C., & Habener, J. F. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112855 · Cited by 882 · cited 1×
“Among its numerous physiological effects (3), GLP-1 increases insulin and decreases glucagon secretion in a glucose-dependent manner (4,5), slows gastric emptying (6), increases glucose disposal, and decreases appetite (7).”
BackgroundMarre, M., Shaw, J., Brändle, M., Bebakar, W. M. W., Kamaruddin, N. A., Strand, J., Zdravkovic, M., Le Thi, T. D., Colagiuri, S., & on behalf of the LEAD‐1 SU study group (2009) · Diabetic Medicine · doi:10.1111/j.1464-5491.2009.02666.x · Cited by 820
Sirt1 protects against high-fat diet-induced metabolic damage
Pfluger, P. T., Herranz, D., Velasco-Miguel, S., Serrano, M., & Tschöp, M. H. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802917105 · Cited by 818 · cited 1×
“To this aim, we used mice with moderate overexpression of SIRT1 under the control of its natural promoter (35) and p53 null mice (33).”
MethodSelf-citationNathan, D. M., Buse, J. B., Davidson, M. B., Ferrannini, E., Holman, R. R., Sherwin, R., & Zinman, B. (2009) · Diabetologia · doi:10.1007/s00125-008-1157-y · Cited by 712
Hypothalamic AMPK and fatty acid metabolism mediate thyroid regulation of energy balance
López, M., Varela, L., Vázquez, M. J., Rodríguez-Cuenca, S., González, C. R., Velagapudi, V. R., Morgan, D. A., Schoenmakers, E., Agassandian, K., Lage, R., et al. (2010) · Nature Medicine · doi:10.1038/nm.2207 · Cited by 681 · cited 10×
“Therefore, to demonstrate the relevance of hypothalamic AMPK as a mediator of the actions of liraglutide, we used a pharmacological activator of AMPK, AICAR (25).”
BackgroundMethodInfluentialSelf-citationThe role of gut hormones in glucose homeostasis
Drucker, D. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30076 · Cited by 614 · cited 1×
“GLP-1 is an incretin hormone released by L cells located in the ileum and colon into the bloodstream postprandially (1,2).”
BackgroundCentral administration of GLP-1-(7-36) amide inhibits food and water intake in rats
Tang-Christensen, M., Larsen, P. J., Goke, R., Fink-Jensen, A., Jessop, D. S., Moller, M., & Sheikh, S. P. (1996) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1996.271.4.r848 · Cited by 597 · cited 1×
“In the hypothalamus, GLP-1 acts as a physiological satiety factor (7), and dose-dependent central administration of GLP-1 reduces feeding in rats (12).”
BackgroundWillms, B., Werner, J., Holst, J. J., Orskov, C., Creutzfeldt, W., & Nauck, M. A. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.1.8550773 · Cited by 502 · cited 1×
“Among its numerous physiological effects (3), GLP-1 increases insulin and decreases glucagon secretion in a glucose-dependent manner (4,5), slows gastric emptying (6), increases glucose disposal, and decreases appetite (7).”
BackgroundGöke, R., Larsen, P. J., Mikkelsen, J. D., & Sheikh, S. P. (1995) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1995.tb00650.x · Cited by 474 · cited 3×
“Indeed, it is well established that the GLP-1R is also located in extrahypothalamic areas (8,9); therefore, the current results do not exclude the possibility that extrahypothalamic areas are also involved in the effects of GLP-1R agonists on BAT thermogenesis and energy expenditure.”
BackgroundArcuate Glucagon-Like Peptide 1 Receptors Regulate Glucose Homeostasis but Not Food Intake
Sandoval, D. A., Bagnol, D., Woods, S. C., D'Alessio, D. A., & Seeley, R. J. (2008) · Diabetes · doi:10.2337/db07-1824 · Cited by 320 · cited 2×
“The reduced food intake observed after the administration of liraglutide in the ARC might seem controversial because a previous study showed that ARC GLP-1R regulates glucose homeostasis but not feeding (14).”
BackgroundKinzig, K. P., D'Alessio, D. A., & Seeley, R. J. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-23-10470.2002 · Cited by 296 · cited 1×
“Stimulation of the central GLP-1 system not only suppresses food intake but also regulates glucose homeostasis (14), behavioral responses to stress (15), and visceral illness (16).”
BackgroundTan, T. M., Field, B. C. T., McCullough, K. A., Troke, R. C., Chambers, E. S., Salem, V., Gonzalez Maffe, J., Baynes, K. C. R., De Silva, A., Viardot, A., et al. (2013) · Diabetes · doi:10.2337/db12-0797 · Cited by 258
Larsen, P. J., Fledelius, C., Knudsen, L. B., & Tang-Christensen, M. (2001) · Diabetes · doi:10.2337/diabetes.50.11.2530 · Cited by 257 · cited 1×
“In addition to its antidiabetic properties, the systemic administration of liraglutide induces weight loss in obese rats (39) and patients (20).”
BackgroundLockie, S. H., Heppner, K. M., Chaudhary, N., Chabenne, J. R., Morgan, D. A., Veyrat-Durebex, C., Ananthakrishnan, G., Rohner-Jeanrenaud, F., Drucker, D. J., DiMarchi, R., et al. (2012) · Diabetes · doi:10.2337/db11-1556 · Cited by 237 · cited 7×
“This effect is likely mediated by the increased activity of sympathetic fibers innervating WAT, as previously reported for BAT (18).”
BackgroundMethodResultInfluentialHarder, H., Nielsen, L., Thi, T. D. T., & Astrup, A. (2004) · Diabetes Care · doi:10.2337/diacare.27.8.1915 · Cited by 232 · cited 2×
“The apparent discrepancies in the results can be explained by the length of the treatment period; in previous studies, patients were treated with GLP-1 agonists for 4 (48), 8 (46), Figure 6—REE in obese T2D patients before and after the treatment for 1 year with metformin (A), metformin and exenatide (B), and metformi…”
ResultCirculating omentin concentration increases after weight loss
Moreno-Navarrete, J. M., Catalán, V., Ortega, F., Gómez-Ambrosi, J., Ricart, W., Frühbeck, G., & Fernández-Real, J. M. (2010) · Nutrition & Metabolism · doi:10.1186/1743-7075-7-27 · Cited by 229 · cited 2×
“Indirect Calorimetry Resting energy expenditure (REE) and respiratory quotient (RQ) were determined by indirect calorimetry after a 12-h overnight fast by using an open-air circuit–ventilated canopy measurement system (Vmax29; SensorMedics Corporation, Yorba Linda, CA) (27).”
MethodSelf-citationKinzig, K. P., D'Alessio, D. A., Herman, J. P., Sakai, R. R., Vahl, T. P., Figueiredo, H. F., Murphy, E. K., & Seeley, R. J. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-15-06163.2003 · Cited by 219 · cited 1×
“Stimulation of the central GLP-1 system not only suppresses food intake but also regulates glucose homeostasis (14), behavioral responses to stress (15), and visceral illness (16).”
BackgroundProinflammatory Cytokines in Obesity: Impact of Type 2 Diabetes Mellitus and Gastric Bypass
Catalán, V., Gómez-Ambrosi, J., Ramirez, B., Rotellar, F., Pastor, C., Silva, C., Rodríguez, A., Gil, M. J., Cienfuegos, J. A., & Frühbeck, G. (2007) · Obesity Surgery · doi:10.1007/s11695-008-9424-z · Cited by 206 · cited 1×
“Blood Determinations Blood determinations were performed as previously described (22,30).”
MethodSelf-citationIncretin hormones and the satiation signal
Holst, J. J. (2013) · International Journal of Obesity · doi:10.1038/ijo.2012.208 · Cited by 188 · cited 1×
“Finally, cells with GLP-1 mRNA are widely expressed in human brain areas (11).”
BackgroundNogueiras, R., Pérez-Tilve, D., Veyrat-Durebex, C., Morgan, D. A., Varela, L., Haynes, W. G., Patterson, J. T., Disse, E., Pfluger, P. T., López, M., et al. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5977-08.2009 · Cited by 182 · cited 4×
“In agreement with previous findings (7,17,18), we found that the central stimulation of GLP-1R reduces food intake and body weight.”
BackgroundMethodResultInfluentialSelf-citationGlucagon-like peptide-1 receptor (GLP1-R) mRNA in the rat hypothalamus
Shughrue, P. J. (1996) · Endocrinology · doi:10.1210/en.137.11.5159 · Cited by 182 · cited 7×
“We report that the CNS GLP-1 system directly activates BAT thermogenesis and browning of white adipocytes.”
BackgroundInfluentialHorowitz, M., Flint, A., Jones, K. L., Hindsberger, C., Rasmussen, M. F., Kapitza, C., Doran, S., Jax, T., Zdravkovic, M., & Chapman, I. M. (2012) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.02.016 · Cited by 179 · cited 1×
“The apparent discrepancies in the results can be explained by the length of the treatment period; in previous studies, patients were treated with GLP-1 agonists for 4 (48), 8 (46), Figure 6—REE in obese T2D patients before and after the treatment for 1 year with metformin (A), metformin and exenatide (B), and metformi…”
ResultIdentification and Localization of Glucagon-Like Peptide-1 and Its Receptor in Rat Brain*
SHIMIZU, I., HIROTA, M., OHBOSHI, C., & SHIMA, K. (1987) · Endocrinology · doi:10.1210/endo-121-3-1076 · Cited by 174
López, M., Lelliott, C. J., Tovar, S. A., Kimber, W. L., Gallego, R., Virtue, S., Blount, M. A., Vazquez, M. J., Finer, N., Powles, T. J., et al. (2006) · Diabetes · doi:10.2337/db05-1356 · Cited by 165 · cited 2×
“Conditioned taste aversion (CTA) was expressed as the percent saccharin preference ratio [(100 3 saccharin intake)/(saccharin intake + water intake)].”
BackgroundSelf-citationCryer, P. E. (2006) · Diabetologia · doi:10.1007/s00125-006-0448-4 · Cited by 161
The Central Sirtuin 1/p53 Pathway Is Essential for the Orexigenic Action of Ghrelin
Velásquez, D. A., Martínez, G., Romero, A., Vázquez, M. J., Boit, K. D., Dopeso-Reyes, I. G., López, M., Vidal, A., Nogueiras, R., & Diéguez, C. (2011) · Diabetes · doi:10.2337/db10-0802 · Cited by 161 · cited 3×
“To this aim, we used mice with moderate overexpression of SIRT1 under the control of its natural promoter (35) and p53 null mice (33).”
BackgroundMethodSelf-citationNicotine Induces Negative Energy Balance Through Hypothalamic AMP-Activated Protein Kinase
Martínez de Morentin, P. B., Whittle, A. J., Fernø, J., Nogueiras, R., Diéguez, C., Vidal-Puig, A., & López, M. (2012) · Diabetes · doi:10.2337/db11-1079 · Cited by 156 · cited 3×
“AMPK Within the VMH Is Essential for the Central Actions of Liraglutide on BAT and WAT Because previous reports have demonstrated a key role of AMPK within the VMH in the regulation of BAT thermogenesis (25,26), we first assessed hypothalamic pAMPK levels after ICV injection of liraglutide.”
BackgroundMethodSelf-citationSeo, S., Ju, S., Chung, H., Lee, D., & Seungjoon, P. A. R. K. (2008) · Endocrine Journal · doi:10.1507/endocrj.k08e-091 · Cited by 125 · cited 1×
“Central GLP-1 administration blunted fasting-induced neuropeptide Y and Agouti-related peptide levels and fasting-reduced proopiomelanocortin and cocaine- and amphetamineregulated transcript expression (13).”
BackgroundAssessment of the physical activity level with two questions: validation with doubly labeled water
Johansson, G., & Westerterp, K. R. (2008) · International Journal of Obesity · doi:10.1038/ijo.2008.42 · Cited by 125 · cited 1×
“The physical activity level (PAL) was assessed by a questionnaire validated with doubly labeled water (29).”
MethodA Modified Method for the Indirect Quantitative Analysis of Phytate in Foodstuffs
Frühbeck, G., Alonso, R., Marzo, F., & Santidrián, S. (1995) · Analytical Biochemistry · doi:10.1006/abio.1995.1145 · Cited by 123 · cited 1×
“After adjustment for body composition, the measured REE was compared with predicted REE according to age- and sex-specific equations (28).”
MethodSelf-citationImbernón, M., Beiroa, D., Vazquez, M. J., Morgan, D. A., Veyrat‐Durebex, C., Porteiro, B., Díaz–Arteaga, A., Senra, A., Busquets, S., Velasquez, D., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.10.051 · Cited by 110 · cited 5×
“Immunohistochemistry and Immunofluorescence Rat brains were fixed, and diaminobenzidine immunohistochemistry and detection of GFP were performed as previously reported (22,25).”
MethodInfluentialSelf-citationKotz, C. M., Grace, M. K., Briggs, J., Levine, A., & Billington, C. J. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118017 · Cited by 90
Glucagon‐like peptide‐1(7–36) amide is a new incretin/enterogastrone candidate
Göke, R., Fehmann, H. C., & Göke, B. (1991) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1991.tb01802.x · Cited by 90 · cited 1×
“GLP-1 is an incretin hormone released by L cells located in the ileum and colon into the bloodstream postprandially (1,2).”
BackgroundMice lacking δ‐opioid receptors resist the development of diet‐induced obesity
Czyzyk, T. A., Romero, A., Pintar, J. E., McKinzie, J. H., Tschöp, M. H., Statnick, M. A., & Nogueiras, R. (2012) · The FASEB Journal · doi:10.1096/fj.12-208041 · Cited by 75
Self-citationDifferences in the Central Anorectic Effects of Glucagon-Like Peptide-1 and Exendin-4 in Rats
Barrera, J. G., D’Alessio, D. A., Drucker, D. J., Woods, S. C., & Seeley, R. J. (2009) · Diabetes · doi:10.2337/db09-0281 · Cited by 69 · cited 2×
“We next compared the central effects of liraglutide versus GLP-1 at 1 mg/mouse, a dose adapted from previous studies (31,32).”
MethodResultHwa, J. J., Ghibaudi, L., Williams, P., Witten, M. B., Tedesco, R., & Strader, C. D. (1998) · Peptides · doi:10.1016/s0196-9781(98)00033-3 · Cited by 58
Alterations in energy balance following exenatide administration
Bradley, D. P., Kulstad, R., Racine, N. M., Shenker, Y., Meredith, M., & Schoeller, D. A. (2012) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h2012-068 · Cited by 54 · cited 2×
“The HbA1c reductions observed were consistent with those from other studies of exenatide and liraglutide (20,46,47).”
BackgroundResultSkibicka, K. P., Alhadeff, A. L., & Grill, H. J. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.6144-08.2009 · Cited by 46
Role of inferior olive and thoracic IML neurons in nonshivering thermogenesis in rats
Uno, T., & Shibata, M. (2001) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.2001.280.2.r536 · Cited by 35 · cited 1×
“In particular, GLP-1 binding sites were found in the inferior olive and nucleus of the solitary tract (9); both areas have been described as involved in the control of thermogenesis (40,41).”
BackgroundRiediger, T., Eisele, N., Scheel, C., & Lutz, T. A. (2010) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00438.2009 · Cited by 31 · cited 1×
“Furthermore, GLP-1 inhibits ghrelin-stimulated neuronal activity in the hypothalamus as well as its effects on food intake (34).”
Background
Cited by
Glucagon-like peptide 1 (GLP-1)
Müller, T. D., Finan, B., Bloom, S. R., D'Alessio, D., Drucker, D. J., Flatt, P. R., Fritsche, A., Gribble, F., Grill, H. J., Habener, J. F., et al. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.09.010 · Cited by 1,868
“In rats, liraglutide decreases food intake when directly injected into the ARC, LHA, or PVN while direct administration into the VMH decreases body weight without affecting food intake, but increases the expression of Ucp1 in the brown and inguinal white adipose tissue [666].”
BackgroundBrown and Beige Fat: Physiological Roles beyond Heat Generation
Kajimura, S., Spiegelman, B. M., & Seale, P. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.09.007 · Cited by 1,001
“…et al., 2010; Qiang et al., 2012), FXR agonist fexaramine (Fang et al., 2015), soluble guanylyl cyclase (Hoffmann et al., 2015), GLP-1 agonist (Beiroa et al., 2014), Notch inhibitor (Bi et al., 2014), and amlexanox, an inhibitor of TBK1 and IKK-e (Reilly et al., 2013), potently increase…”
BackgroundEpicardial adipose tissue in contemporary cardiology
Iacobellis, G. (2022) · Nature Reviews Cardiology · doi:10.1038/s41569-022-00679-9 · Cited by 797
Adipose tissue in control of metabolism
Luo, L., & Liu, M. (2016) · Journal of Endocrinology · doi:10.1530/joe-16-0211 · Cited by 693
Yoon, H. S., Cho, C. H., Yun, M. S., Jang, S. J., You, H. J., Kim, J.-H., Han, D., Cha, K. H., Moon, S. H., Lee, K., et al. (2021) · Nature Microbiology · doi:10.1038/s41564-021-00880-5 · Cited by 602
“GLUTag and NCI-H716 cells were incubated with an ICAM-2-blocking peptide (MBS823225; MyBioSource), anti-ICAM-2 antibodies (BD Pharmigen, 3C4 (mIC2/4); BD553326), anti-total KTN1 antibodies (A44072; Antibody Solutions) or a negative control antibody (mouse anti-β tubulin (32-2600); Thermo Fisher Scientific) for 1 h, be…”
Method
Metadata
- Authors
- Beiroa, D., Imbernon, M., Gallego, R., Senra, A., Herranz, D., Villarroya, F., Serrano, M., Fernø, J., Salvador, J., Escalada, J., Dieguez, C., Lopez, M., Frühbeck, G., & Nogueiras, R.
- Affiliations
- Universidade de Santiago de Compostela (ES)
- Department of Physiology, CIMUS, University of Santiago de Compostela-Instituto de Investigación Sanitaria, Santiago de Compostela, Spain
- Department of Morphological Sciences, School of Medicine, University of Santiago de Compostela-Instituto de Investigación Sanitaria, Santiago de Compostela, Spain
- Spanish National Cancer Research Centre (ES)
- Centro de Investigación Biomédica en Red (ES)
- University of Bergen (NO)
- ORCID
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2014-09-15
- Volume
- 63
- Issue
- 10
- Pages
- 3346-3358
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2108365604
- Cited by
- 602
- References
- 52
- Citations by year
- 2026: 42 · 2025: 63 · 2024: 60 · 2023: 51 · 2022: 57 · 2021: 59 · 2020: 38 · 2019: 44 · 2018: 46 · 2017: 43 · 2016: 49 · 2015: 41 · 2014: 8
- FWCI
- 31.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- GLP-1 receptor agonists, liraglutide, exenatide, brown adipose tissue thermogenesis, adipocyte browning, ventromedial hypothalamus, AMPK, energy expenditure, food intake regulation, body weight, obesity, type 2 diabetes, central nervous system
- MeSH terms
- Liraglutide, Exenatide, AMP-Activated Protein Kinase Kinases, Adult, Aged, Aged, 80 and over, Animals, Adipose Tissue, Brown, Diabetes Mellitus, Type 2, Drug Therapy, Combination, Eating, Energy Metabolism, Female, Humans, Hypoglycemic Agents, Hypothalamus, Male, Metformin, Middle Aged, Obesity, Peptides, Protein Kinases, Venoms, Thermogenesis, Mice, Rats, Glucagon-Like Peptide 1, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.